Literature DB >> 21422281

Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

Jennie S Lavine1, Aaron A King, Ottar N Bjørnstad.   

Abstract

Incidence of whooping cough, unlike many other childhood diseases for which there is an efficacious vaccine, has been increasing over the past twenty years despite high levels of vaccine coverage. Its reemergence has been particularly noticeable among teenagers and adults. Many hypotheses have been put forward to explain these two patterns, but parsimonious reconciliation of clinical data on the limited duration of immunity with both pre- and postvaccine era age-specific incidence remains a challenge. We consider the immunologically relevant, yet epidemiologically largely neglected, possibility that a primed immune system can respond to a lower dose of antigen than a naive one. We hypothesize that during the prevaccine era teenagers' and adults' primed immunity was frequently boosted by reexposure, so maintaining herd immunity in the face of potentially eroding individual immunity. In contrast, low pathogen circulation in the current era, except during epidemic outbreaks, allows immunity to be lost before reexposure occurs. We develop and analyze an age-structured model that encapsulates this hypothesis. We find that immune boosting must be more easily triggered than primary infection to account for age-incidence data. We make age-specific and dynamical predictions through bifurcation analysis and simulation. The boosting model proposed here parsimoniously captures four key features of pertussis data from highly vaccinated countries: (i) the shift in age-specific incidence, (ii) reemergence with high vaccine coverage, (iii) the possibility for cyclic dynamics in the pre- and postvaccine eras, and (iv) the apparent shift from susceptible-infectious-recovered (SIR)-like to susceptible-infectious-recovered-susceptible (SIRS)-like phenomenology of infection and immunity to Bordetella pertussis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422281      PMCID: PMC3084147          DOI: 10.1073/pnas.1014394108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis.

Authors:  P F M Teunis; O G van der Heijden; H E de Melker; J F P Schellekens; F G A Versteegh; M E E Kretzschmar
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

2.  Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives.

Authors:  M Gabriela M Gomes; Lisa J White; Graham F Medley
Journal:  J Theor Biol       Date:  2004-06-21       Impact factor: 2.691

3.  Whooping cough and its epidemiological anomalies.

Authors:  J E GORDON; R I HOOD
Journal:  Am J Med Sci       Date:  1951-09       Impact factor: 2.378

Review 4.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

5.  The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.

Authors:  L A Cattaneo; G W Reed; D H Haase; M J Wills; K M Edwards
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

6.  Return of epidemic pertussis in the United States.

Authors:  J W Bass; R R Wittler
Journal:  Pediatr Infect Dis J       Date:  1994-05       Impact factor: 2.129

7.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

Review 8.  Epidemiology of pertussis.

Authors:  Tina Tan; Evelinda Trindade; Danuta Skowronski
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

9.  Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.

Authors:  Robin de Vries; Mirjam Kretzschmar; Joop F P Schellekens; Florens G A Versteegh; Tjalke A Westra; John J Roord; Maarten J Postma
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

10.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more
  66 in total

1.  Modelling the long-term dynamics of pre-vaccination pertussis.

Authors:  Ganna Rozhnova; Ana Nunes
Journal:  J R Soc Interface       Date:  2012-06-20       Impact factor: 4.118

2.  Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.

Authors:  Julie C Blackwood; Derek A T Cummings; Hélène Broutin; Sopon Iamsirithaworn; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

3.  Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies.

Authors:  Erinn Sanstead; Nicole E Basta; Karen Martin; Victor Cruz; Kristen Ehresmann; Shalini Kulasingam
Journal:  J Community Health       Date:  2018-10

4.  Boosting understanding of pertussis outbreaks.

Authors:  Bryan Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-20       Impact factor: 11.205

5.  Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Authors:  Maria A Riolo; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

6.  Core pertussis transmission groups in England and Wales: A tale of two eras.

Authors:  Ana I Bento; Maria A Riolo; Yoon H Choi; Aaron A King; Pejman Rohani
Journal:  Vaccine       Date:  2018-02-01       Impact factor: 3.641

7.  Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

Authors:  J C Blackwood; D A T Cummings; S Iamsirithaworn; P Rohani
Journal:  Epidemics       Date:  2016-03-19       Impact factor: 4.396

8.  Critical transitions in malaria transmission models are consistently generated by superinfection.

Authors:  David Alonso; Andy Dobson; Mercedes Pascual
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-06-24       Impact factor: 6.237

Review 9.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 10.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.